基础医学与临床 ›› 2026, Vol. 46 ›› Issue (2): 170-176.doi: 10.16352/j.issn.1001-6325.2026.02.0170

• 研究论文 • 上一篇    下一篇

miR-218-5p减轻高糖诱导的小鼠肾足细胞系MPC5损伤

余渊1, 胡艺琼1*, 向庆伟2   

  1. 1.黄石市中心医院 (湖北理工学院第一临床学院) 内分泌科, 湖北 黄石 435000;
    2.湖北省中医院 老年病科, 湖北 武汉 430000
  • 收稿日期:2025-02-28 修回日期:2025-04-29 出版日期:2026-02-05 发布日期:2026-01-21
  • 通讯作者: * koyueo@163.com
  • 基金资助:
    湖北省卫生健康委员会资助项目 (ZY2021Q037)

miR-218-5p alleviates high glucose-induced injury in mouse podocyte MPC5

YU Yuan1, HU Yiqiong1*, XIANG Qingwei2   

  1. 1. Department of Endocrinology, Huangshi Central Hospital (the First Clinical College of Hubei Institute of Technology), Huangshi 435000;
    2. Department of Geriatrics, Hubei Hospital of Traditional Chinese Medicine, Wuhan 430000, China
  • Received:2025-02-28 Revised:2025-04-29 Online:2026-02-05 Published:2026-01-21
  • Contact: * koyueo@163.com

摘要: 目的 探讨miR-218-5p调控基质金属蛋白酶组织抑制因子2(TIMP2)在高糖(HG)诱导小鼠肾足细胞系MPC5损伤中的作用及其机制。方法 将MPC5细胞分为对照组、HG组、NC-mimics组、miR-218-5p-mimics组、miR-218-5p-mimics+pcDNA-NC组和miR-218-5p-mimics+pcDNA-TIMP2组。除对照组外,其余各组均采用30 mmol/L葡萄糖处理24 h。采用RT-qPCR检测miR-218-5p和TIMP2 mRNA的表达水平;CCK-8法与流式细胞术分别检测细胞增殖与凋亡;ELISA试剂盒检测活性氧(ROS)、超氧化物歧化酶(SOD)活性和丙二醛(MDA)含量;Western blot检测相关蛋白表达;双荧光素酶报告基因实验验证miR-218-5p与TIMP2的靶向关系。结果 与对照组相比,HG组A450值、miR-218-5p表达和SOD活性降低,细胞凋亡率、TIMP2 mRNA和蛋白表达、ROS活性、MDA含量及cleaved caspase-3表达均升高(P<0.05)。与HG组和NC-mimics组相比,miR-218-5p-mimics组的A450值、miR-218-5p表达和SOD活性升高,而凋亡率、TIMP2 mRNA和蛋白表达、ROS活性、MDA含量及cleaved caspase-3表达均降低(P<0.05)。与miR-218-5p-mimics组和miR-218-5p-mimics+pcDNA-NC组相比,miR-218-5p-mimics+pcDNA-TIMP2组的A450值和SOD活性降低,而凋亡率、TIMP2 mRNA和蛋白表达、ROS活性、MDA含量及cleaved caspase-3表达均升高(P<0.05)。双荧光素酶报告基因实验证实miR-218-5p可靶向负调控TIMP2。结论 miR-218-5p过表达可减轻高糖诱导的足细胞损伤,其保护作用可能通过靶向负调控TIMP2实现。

关键词: miR-218-5p, 基质金属蛋白酶抑制因子2, 高糖, 糖尿病肾病, 足细胞损伤

Abstract: Objective To investigate the effect of miR-218-5p on high glucose (HG)-induced injury in a mouse podocyte cell line MPC5 and its potential mechanism involving targeting tissue inhibitor of metalloproteinase 2 (TIMP2). Methods MPC5 cells were divided into the following groups: control group, HG group, NC-mimics group, miR-218-5p-mimics group, miR-218-5p-mimics+pcDNA-NC group, and miR-218-5p-mimics+pcDNA-TIMP2 group. All groups except the control group were treated with 30 mmol/L glucose for 24 hours to induce injury.The expression levels of miR-218-5p and TIMP2 mRNA were detected by RT-qPCR. Cell proliferation and apoptosis were assessed using the CCK-8 assay and flow cytometry, respectively. The activities of reactive oxygen species (ROS) and superoxide dismutase (SOD), as well as the content of malondialdehyde (MDA), were measured using ELISA kits. Protein expression levels were detected by Western blot. The targeting relationship between miR-218-5p and TIMP2 was verified by a dual-luciferase reporter assay. Results Compared with the control group, the HG group showed decreased A450 value, miR-218-5p expression, and SOD activity, but increased apoptosis rate, TIMP2 mRNA and protein expression, ROS activity, MDA content, and cleaved caspase-3 expression (P<0.05). Compared with the HG and NC-mimics groups, the miR-218-5p-mimics group exhibited an increased A450 value, elevated miR-218-5p expression, and higher SOD activity, whereas the apoptosis rate, TIMP2 mRNA and protein expression, ROS activity, MDA content, and cleaved caspase-3 expression were decreased (P<0.05). Furthermore, compared with the miR-218-5p-mimics group and the miR-218-5p-mimics+pcDNA-NC group, the miR-218-5p-mimics+pcDNA-TIMP2 group displayed a reduced A450 value and SOD activity, alongside an increased apoptosis rate, elevated TIMP2 mRNA and protein expression, higher ROS activity, increased MDA content, and enhanced cleaved caspase-3 expression (P<0.05).The dual-luciferase reporter assay confirmed that miR-218-5p could directly target and negatively regulate TIMP2. Conclusions Overexpression of miR-218-5p protects against HG-induced podocyte injury, and this protective effect may be mediated through the negative regulation of TIMP2.

Key words: miR-218-5p, matrix metalloproteinase inhibitor 2, high glucose, diabetic kidney disease, podocyte injury

中图分类号: